Entry in Pharmaceutical submarkets: A Bayesian Panel Probit Approach

Gianni Amisano and Maria Letizia Giorgetti

Working Papers from University of Brescia, Department of Economics

Abstract: In this paper we analyze entry dynamics in new submarkets of pharma- ceutical companies in the period 1987-1998 in seven countries considered as a single country and on each country separately. In particular we study entry decisions at time t in a new submarket, conditioned on the entrance or non-entrance in a new submarket at time t-1. Our analysis is based on a Bayesian approach which allows us to properly account for hetero- geneity among firms. We try to manage the inclusion among regressors of non strictly exogenous variables, which can be correlated with unobserved heterogeneity. Reassuming, the relevant variables are the achieved diver- sification indipendently of the size and other strategic variables connected with the attractiveness of each submarket. The unobservable heterogeneity is not explained by the lagged dependent variable but rather by the initial diversification.

Date: 2005
New Economics Papers: this item is included in nep-com, nep-hea and nep-tid
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.unibs.it/on-line/dse/Home/Inevidenza/Pa ... o/documento4598.html
Our link check indicates that this URL is bad, the error code is: 403 Forbidden

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ubs:wpaper:ubs0511

Access Statistics for this paper

More papers in Working Papers from University of Brescia, Department of Economics Contact information at EDIRC.
Bibliographic data for series maintained by Matteo Galizzi ( this e-mail address is bad, please contact ).